Axsome shares jump as settlement will keep Teva's Auvelity generic off the market until 2038
10th February 2025 Uncategorised 0Shares of Axsome Therapeutics jumped by more than 20% after the company resolved a patent infringement lawsuit against Teva Pharmaceuticals. The settlement will keep Teva’s generic version of Axsome’s major depressive disorder drug Auvelity off the market until at least 2038.
More: Axsome shares jump as settlement will keep Teva's Auvelity generic off the market until 2038
Source: fierce